Phase II Study of Irinotecan Plus Panitumumab as Second-Line Therapy for Patients with Advanced Esophageal Adenocarcinoma
| Image |  |
|---|---|
| Description | scientific article published on 16 May 2018 |
| Author/s |
author: Michael K. Gibson |
| Publication date | May 16, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |